PHI recently joined forces with the Huntsman Cancer Institute in the battle against cancer. Using PHI's HoloMonitor technology, the researchers at Huntsman aim to develop improved methods for quantifying the phenomena that regulate tumors' ability to metastasize.
Read the commentary here.
